Topic
Gilead Sciences
There's no treatment designed for the Ebola strain ravaging DRC. But now there's hope
With no licensed vaccines for the rare Bundibugyo strain of Ebola, researchers are testing repurposed antiviral drugs and monoclonal antibodies in the DRC.